Elena Martinelli

Prof. Dr. Elena Martinelli

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2008 in Nature Immunology
Verified
Journal Article
Closed access
JAJames Arthos
James Arthos
CCClaudia Cicala
Claudia Cicala
EMElena Martinelli
Elena Martinelli
KMKatilyn Macleod
Katilyn Macleod
DRDonald Van Ryk
Donald Van Ryk
AFAnthony S Fauci
Anthony S Fauci

8 December 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CCClaudia Cicala
Claudia Cicala
EMElena Martinelli
Elena Martinelli
JMJonathan P. McNally
Jonathan P. McNally
DGDiana J. Goode
Diana J. Goode
RGRavindra Gopaul
Ravindra Gopaul
JAJames Arthos
James Arthos
Both activated and resting CD4 + T cells in mucosal tissues play important roles in the earliest phases of infection after sexual transmission of HIV-1, a process that is inefficient. HIV-1 gp120 binds to integrin α 4 β 7 (α 4 β 7 ), the gut mucosal homing receptor. We find that α 4 β 7 high CD4 + T cells are more susceptible to productive infection than are α 4 β 7 low-neg CD4 + T cells in part because this cellular subset is enriched with metabolically active CD4 + T cells. α 4 β 7 high CD4 + T cells are CCR5 high and CXCR4 low ; on these cells, α 4 β 7 appears in a complex with CD4. The specific affinity of gp120 for α 4 β 7 provides a mechanism for HIV-1 to target activated cells that are critical for efficient virus propagation and dissemination following sexual transmission.

27 February 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
EMElena Martinelli
Elena Martinelli
CCClaudia Cicala
Claudia Cicala
DRDonald Van Ryk
Donald Van Ryk
DGDiana J. Goode
Diana J. Goode
KMKatilyn Macleod
Katilyn Macleod
AFAnthony S. Fauci
Anthony S. Fauci
Plasmacytoid dendritic cells (pDCs) play a central role in innate and adaptive immune responses against viral infections. pDCs secrete type I IFNs and proinflammatory cytokines upon stimulation by either TLR7 or TLR9. Throughout the course of HIV infection, the production of type-I IFNs is profoundly impaired, and total pDC cell counts in peripheral blood correlates inversely with viral load and positively with CD4+T cell count. The origin of these defects is unclear. pDCs express CD4, CCR5, and CXCR4, the primary receptor and coreceptors, respectively, for the HIV envelope; yet little is known concerning the effects of the viral envelope on these cells. Here, we show that exposure of pDCs to gp120 results in the suppression of activation of these cells. This suppression is specific for TLR9-mediated responses, because TLR7-mediated responses are unaffected by gp120. gp120 also suppressed TLR9-mediated induction of proinflammatory cytokines and expression of CD83, a marker of DC activation. Finally, gp120 suppressed pDC-induced cytolytic activity of natural killer cells. Taken together, these data demonstrate that the direct interaction of HIV-1 gp120 with pDCs interferes with TLR9 activation resulting in a decreased ability of pDCs to secrete antiviral and inflammatory factors that play a central role in initiating host immune responses against invading pathogens.

8 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZZZhongcheng Zou
Zhongcheng Zou
ACAshley Chastain
Ashley Chastain
SMSusan Moir
Susan Moir
JFJennifer Ford
Jennifer Ford
KTKathryn Trandem
Kathryn Trandem
PSPeter D Sun
Peter D Sun
Human immunodeficiency virus type 1 (HIV-1) infects macrophages effectively, despite relatively low levels of cell surface-expressed CD4. Although HIV-1 infections are defined by viral tropisms according to chemokine receptor usage (R5 and X4), variations in infection are common within both R5- and X4-tropic viruses, indicating additional factors may contribute to viral tropism. Using both solution and cell surface binding experiments, we showed that R5- and X4-tropic HIV-1 gp120 proteins recognized a family of I-type lectin receptors, the Sialic acid-binding immunoglobulin-like lectins (Siglec). The recognition was through envelope-associated sialic acids that promoted viral adhesion to macrophages. The sialic acid-mediated viral-host interaction facilitated both R5-tropic pseudovirus and HIV-1BaL infection of macrophages. The high affinity Siglec-1 contributed the most to HIV-1 infection and the variation in Siglec-1 expression on primary macrophages from different donors was associated statistically with sialic acid-facilitated viral infection. Furthermore, envelope-associated sialoglycan variations on various strains of R5-tropic viruses also affected infection. Our study showed that sialic acids on the viral envelope facilitated HIV-1 infection of macrophages through interacting with Siglec receptors, and the expression of Siglec-1 correlated with viral sialic acid-mediated host attachment. This glycan-mediated viral adhesion underscores the importance of viral sialic acids in HIV infection and pathogenesis, and suggests a novel class of antiviral compounds targeting Siglec receptors.

1 August 2005 in Journal of Virology
Verified
Journal Article
Open access
PDF file
DDDonatella Donati
Donatella Donati
EMElena Martinelli
Elena Martinelli
RCRiccardo Cassiani-Ingoni
Riccardo Cassiani-Ingoni
JAJenny Ahlqvist
Jenny Ahlqvist
JHJean Hou
Jean Hou
SJSteven Jacobson
Steven Jacobson
Though first described as a lymphotropic virus, human herpesvirus 6 (HHV-6) is highly neuropathogenic. Two viral variants are known: HHV-6A and HHV-6B. Both variants can infect glial cells and have been differentially associated with central nervous system diseases, suggesting an HHV-6 variant-specific tropism for glial cell subtypes. We have performed infections with both viral variants in human progenitor-derived astrocytes (HPDA) and monitored infected cell cultures for cytopathic effect (CPE), intra- and extracellular viral DNA load, the presence of viral particles by electronic microscopy, mRNA transcription, and viral protein expression. HHV-6A established a productive infection with CPE, visible intracellular virions, and high virus DNA loads. HHV-6B-infected HPDA showed no morphological changes, intracellular viral particles, and decreasing intra- and extracellular viral DNA over time. After long-term passage, HHV-6B-infected HPDA had stable but low levels of intracellular viral DNA load with no detectable viral mRNA. Our results demonstrate that HHV-6A and HHV-6B have differential tropisms and patterns of infection for HPDA in vitro, where HHV-6A results in a productive lytic infection. In contrast, HHV-6B was associated with a nonproductive infection. These findings suggest that HHV-6 variants might be responsible for specific infection patterns in glial cells in vivo. Astrocytes may be an important reservoir for this virus in which differential tropism of HHV-6A and HHV-6B may be associated with different disease outcomes.

1 December 2015 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
KLKeith Levendosky
Keith Levendosky
OMOlga Mizenina
Olga Mizenina
EMElena Martinelli
Elena Martinelli
NJNinochka Jean-Pierre
Ninochka Jean-Pierre
LKLarisa Kizima
Larisa Kizima
JFJosé A. Fernández-Romero
José A. Fernández-Romero
Extensive preclinical evaluation of griffithsin (GRFT) has identified this lectin to be a promising broad-spectrum microbicide. We set out to explore the antiviral properties of a GRFT and carrageenan (CG) combination product against herpes simplex virus 2 (HSV-2) and human papillomavirus (HPV) as well as determine the mechanism of action (MOA) of GRFT against both viruses. We performed the experiments in different cell lines, using time-of-addition and temperature dependence experiments to differentiate inhibition of viral attachment from entry and viral receptor internalization. Surface plasmon resonance (SPR) was used to assess GRFT binding to viral glycoproteins, and immunoprecipitation and immunohistochemistry were used to identify the specific glycoprotein involved. We determined the antiviral activity of GRFT against HSV-2 to be a 50% effective concentration (EC 50 ) of 230 nM and provide the first evidence that GRFT has moderate anti-HPV activity (EC 50 = 0.429 to 1.39 μM). GRFT blocks the entry of HSV-2 and HPV into target cells but not the adsorption of HSV-2 and HPV onto target cells. The results of the SPR, immunoprecipitation, and immunohistochemistry analyses of HSV-2 combined suggest that GRFT may block viral entry by binding to HSV-2 glycoprotein D. Cell-based assays suggest anti-HPV activity through α 6 integrin internalization. The GRFT-CG combination product but not GRFT or CG alone reduced HSV-2 vaginal infection in mice when given an hour before challenge ( P = 0.0352). While GRFT significantly protected mice against vaginal HPV infection when dosed during and after HPV16 pseudovirus challenge ( P < 0.026), greater CG-mediated protection was afforded by the GRFT-CG combination for up to 8 h ( P < 0.0022). These findings support the development of the GRFT-CG combination as a broad-spectrum microbicide.